Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Homeopathy legal challenge fails

A legal attempt to overturn NHS England’s decision to reduce NHS prescribing of homeopathic products has failed.

The British Homeopathic Association (BHA) had sought a judicial review of NHS England’s guidance to curb prescriptions for 18 treatments it considered to be of low clinical value.

The guidance to clinical commissioning groups, published in November 2017, ended routine prescribing of treatments including homeopathy, antioxidants and other supplements, which NHS England said would save £140m a year.

The BHA claimed that NHS England’s consultation was unfair and that a report on homeopathy used in the consultation was so complicated that it would deter people from responding. The High Court rejected the BHA’s claims in a ruling published on 5 June 2018.

BHA chair, Margaret Wyllie, said: “It appears NHS England can fail to engage with patients properly on removing services and get away with it. That is not good enough, for it is important to remember that the real losers in this case are the patients who are now being refused a treatment on which they have come to depend.”

NHS England chief executive, Simon Stevens, said: “There is no robust evidence to support homeopathy which is, at best, a placebo and a misuse of scarce NHS funds. So we strongly welcome the High Court’s clear cut decision to kick out this costly and spurious legal challenge.”

Citation: The Pharmaceutical Journal URI: 20204965

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.